2-pyrrolidone has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SY; Chao, TL; Chen, YY; Chiu, YT; Fang, JT; Hu, CW; Kuo, CJ; Li, CW; Liang, PH; Lin, HC; Lin, SW; Lin, WC; Lin, YT; Liu, JJ; Lo, HV; Palla, SR; Pan, MY; Wang, LH; Yang, CM | 1 |
1 other study(ies) available for 2-pyrrolidone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Synthesis, evaluation, and mechanism of 1-(4-(arylethylenylcarbonyl)phenyl)-4-carboxy-2-pyrrolidinones as potent reversible SARS-CoV-2 entry inhibitors.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; COVID-19; Furin; Humans; Pyrrolidinones; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization | 2023 |